Back to top
more

Humana (HUM)

(Delayed Data from NYSE)

$260.71 USD

260.71
1,424,061

+2.88 (1.12%)

Updated Nov 1, 2024 04:00 PM ET

After-Market: $260.81 +0.10 (0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 36% (159 out of 250)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Centene (CNC) Q1 Earnings Beat on Premiums, '24 EPS View Hiked

by Zacks Equity Research

Centene's (CNC) Q1 results reflect strength in the Commercial business line. Management currently expects adjusted EPS to be greater than $6.80 for 2024.

Molina Healthcare (MOH) Q1 Earnings Beat on Growing Membership

by Zacks Equity Research

Molina Healthcare's (MOH) Q1 results reflect strong premium revenue growth. It continues to estimate adjusted EPS at a minimum of $23.50 for 2024.

Humana (HUM) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Revised)

by Zacks Equity Research

Although the revenue and EPS for Humana (HUM) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Premium Growth Propels Humana (HUM) to Easy Q1 Earnings Beat

by Zacks Equity Research

Humana (HUM) bumps up individual Medicare Advantage membership growth guidance.

Humana (HUM) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

by Zacks Equity Research

Although the revenue and EPS for Humana (HUM) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Humana (HUM) Tops Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Humana (HUM) delivered earnings and revenue surprises of 20.10% and 2.55%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Why Earnings Season Could Be Great for Humana (HUM)

by Zacks Equity Research

Humana (HUM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Debasmita Chatterjee headshot

Watch These 5 Medical Stocks for Q1 Earnings: Beat or Miss?

by Debasmita Chatterjee

Improved premiums resulting from membership growth, and higher patient admissions are expected to have driven the Q1 performance of HUM, MOH, UHS, EHC and CYH. An elevated operating expense level is likely to have dented growth prospects.

Will Humana (HUM) Q1 Earnings Beat on CenterWell Strength?

by Zacks Equity Research

Humana's (HUM) first-quarter results are likely to reflect rising premiums and investment income.

Analysts Estimate Centene (CNC) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Centene (CNC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

What Analyst Projections for Key Metrics Reveal About Humana (HUM) Q1 Earnings

by Zacks Equity Research

Evaluate the expected performance of Humana (HUM) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

by Zacks Equity Research

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

Humana (HUM) Ascends While Market Falls: Some Facts to Note

by Zacks Equity Research

Humana (HUM) closed the most recent trading day at $324.83, moving +0.42% from the previous trading session.

Humana (HUM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

by Zacks Equity Research

Humana (HUM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Brokers Suggest Investing in Humana (HUM): Read This Before Placing a Bet

by Zacks Equity Research

According to the average brokerage recommendation (ABR), one should invest in Humana (HUM). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Humana (HUM) Stock Moves -1.17%: What You Should Know

by Zacks Equity Research

In the latest trading session, Humana (HUM) closed at $312.59, marking a -1.17% move from the previous day.

Centene (CNC) Wins Medicaid Contract to Better Serve Michigan

by Zacks Equity Research

Centene's (CNC) Meridian secures a contract from the Michigan Department of Health and Human Services, which gives it the opportunity to better serve the health needs of the state's Medicaid members.

CI vs. HUM: Which Stock Is the Better Value Option?

by Zacks Equity Research

CI vs. HUM: Which Stock Is the Better Value Option?

Humana's (HUM) Medicaid Business Teams Up With CPESN USA in Ohio

by Zacks Equity Research

Humana's (HUM) partnership with CPESN USA in Ohio aims to overcome barriers like limited access to healthcare services in rural and underserved communities.

Pre-Markets in Red Before Key Economic Data

by Zacks Equity Research

Pre-Markets in Red Before Key Economic Data.

Mark Vickery headshot

Pre-Market Futures Lower Ahead of JOLTS, U.S. Auto Sales

by Mark Vickery

Markets look to start a new trading day in the red after closing lower Monday. Bond yields, gold and oil are all up.

Kaibalya Pravo Dey headshot

Health Insurance Stocks Drop: Insights Into the Late Monday Fall

by Kaibalya Pravo Dey

Higher costs and lower hikes in rates can lead to lower profit growth, which concerns investors.

Humana (HUM) Increases Despite Market Slip: Here's What You Need to Know

by Zacks Equity Research

Humana (HUM) concluded the recent trading session at $351.45, signifying a +1.36% move from its prior day's close.

Is It Worth Investing in Humana (HUM) Based on Wall Street's Bullish Views?

by Zacks Equity Research

Based on the average brokerage recommendation (ABR), Humana (HUM) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

Humana (HUM) Sees a More Significant Dip Than Broader Market: Some Facts to Know

by Zacks Equity Research

Humana (HUM) closed the most recent trading day at $347.09, moving -0.42% from the previous trading session.